Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain

Related Experiment Video

Updated: May 7, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

10.5K

Lauren L Jantzie1, Robert H Miller2, Shenandoah Robinson1

  • 1Departments of Neurosurgery and Neurology, F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Pediatric Research
|October 11, 2013
PubMed

Insights

Recombinant erythropoietin (rEPO) aids brain injury recovery in preterm infants by promoting oligodendrocyte development and myelination after white matter injury. This suggests EPO treatment may benefit infants with developmental brain injuries.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Regenerative Medicine

Background:

  • Preterm birth can cause white matter injury (WMI), leading to chronic neurological deficits.
  • Immature oligodendrocytes are vulnerable to WMI, impacting brain development.
  • Erythropoietin (EPO) aids neuronal recovery, but its role in oligodendrocyte recovery is unclear.

Purpose of the Study:

  • To investigate the role of recombinant EPO (rEPO) in enhancing oligodendrocyte lineage recovery after prenatal transient systemic hypoxia-ischemia (TSHI).
  • To determine if rEPO promotes oligodendroglial cell genesis, survival, maturation, and myelination post-injury.

Main Methods:

  • In vitro assays were employed to assess rEPO's effects on oligodendrocyte development and recovery.
  • The study focused on specific stages of oligodendrocyte lineage progression after TSHI.

Main Results:

  • rEPO treatment promoted the genesis of oligodendrocyte progenitors and survival of precursor cells and immature oligodendrocytes.
  • rEPO enhanced O4+ cell process extension and myelin basic protein (MBP) expression.
  • rEPO did not significantly alter oligodendrocyte precursor cell proliferation.

Conclusions:

  • EPO signaling promotes key stages of oligodendrocyte development and recovery following prenatal TSHI.
  • EPO treatment shows potential as a therapeutic strategy for infants with developmental brain injury and WMI.
Abstract

More Related Videos

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain14:26

Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain

Published on: December 20, 2012

14.1K
Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions10:53

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions

Published on: November 9, 2020

4.8K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
2.1K